MA05.07 Dose Escalated Chemo-Rt to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results From a Randomized Phase II Trial

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.354
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.01-43 ADSCaN: A Randomised Phase II Study of Accelerated, Dose Escalated, Sequential Chemo-Radiotherapy in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab in Patients With Unresectable Stage III NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated After Chemoradiotherapy and an 8-Year Update on a Phase I/Ii Trial

Clinical Cancer Research
Cancer ResearchOncology
2011English

Fludarabine and 2-Gy TBI Is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial

Journal of the National Cancer Institute
Cancer ResearchOncology
2001English

Toxicity and Biochemical Outcomes of Dose-Intensified Post-Operative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2020English

OA13 High-Dose Icotinib in Advanced NSCLC With EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy